ABL1 and neoplasm: Conversely, nilotinib strongly reduced migration of MDA-MB 231 cells, but not of BT-549 (Fig. 2C) and 3T3 SrcY527F cells (S2 Fig. B), suggesting that ABL does not regulate tumor cell motility on its own.